Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07613593

INCLUDE-CKD: INCLUsive Digital carE for Chronic Kidney Disease

This study will provide valuable insights into the demographics of MyRenalCare users, their digital adherence, and the overall impact of the app on health outcomes, healthcare costs, and environmental sustainability.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

5.1.1 Inclusion criteria - MyRenalCare users (retrospective and prospective cohorts)

Adults will be eligible for inclusion in the MyRenalCare cohorts if they meet all of the following:

  • Aged 18 years or over.
  • Under the care of the Wessex Kidney Centre
  • Registered with, or offered and subsequently enrolled onto, the MyRenalCare platform during the defined retrospective or prospective periods.
  • Able to understand study information and, where applicable, provide informed consent for use of their data for research purposes.

Specific CKD stage definitions and thresholds (e.g. based on eGFR, albuminuria or uPCR) will be documented in the study manual to ensure consistent application.

5.1.2 Inclusion criteria - matched usual care controls

Adults will be eligible for inclusion in the matched control cohorts if they meet all of the following:

  • Aged 18 years or over.
  • Under the care of the Wessex Kidney Centre for chronic kidney disease.
  • Not registered with or using MyRenalCare at any point during the relevant observation period.
  • Have sufficient clinical and administrative data available in the renal electronic patient record to enable matching and outcome assessment.

Controls will be identified retrospectively from the renal electronic patient record and matched to MyRenalCare users using a predefined matching strategy.

5.1.3 Inclusion criteria - qualitative interview participants (patients and staff)

Patients will be eligible to take part in the qualitative interview component if they meet all of the following:

  • Aged 18 years or over.
  • Currently using, or recently offered, the MyRenalCare platform as part of their CKD care at the Wessex Kidney Centre.
  • Able to understand spoken and written English to the extent required for participation in an interview.
  • Able and willing to provide written informed consent for participation in a recorded interview.
  • Belong to a demographic or clinical subgroup of interest for the study (e.g. varying age, ethnicity, CKD stage, or digital engagement level), as part of purposive sampling to support diversity and equity analysis.

Clinical staff will be eligible if they meet all of the following:

  • Employed by PHU or working in direct partnership with the Wessex Kidney Centre.
  • Directly involved in the care of patients with chronic kidney disease and/or in the implementation or support of MyRenalCare.
  • Able and willing to provide informed consent for a recorded interview.
  • Able to reflect on experiences and observations relevant to the delivery, uptake, or equity implications of digital health in CKD.

Exclusion criteria

  • Patients with acute kidney injury without established chronic kidney disease.
  • Patients with a very limited life expectancy where participation in routine digital monitoring is not appropriate, as judged by the clinical team.
  • Patients who have previously indicated that they do not wish their routinely collected clinical data to be used for research where such opt-out applies to this study.
  • Patients who are unable to be identified reliably in the available data sources (for example, inconsistent or missing key identifiers).
  • Any other situation where, in the opinion of the responsible clinician, participation in the study processes (including data use) would be inappropriate or unduly burdensome.
  • Clinical staff who are not directly involved in the care of patients with chronic kidney disease or in the implementation of the MyRenalCare platform.
  • Staff members currently on extended leave or unable to participate during the data collection period.
  • Individuals who do not wish to have their views included in recorded interview transcripts or are unable to provide informed consent for participation.
  • Any situation where, in the opinion of the study team or the individual's manager, participation would be inappropriate or burdensome due to role, availability, or conflict of interest.

Treatment and study plan

Non-Interventional Study

Other

Study is non-interventional.

Other names: non-interventional

Primary outcomes

  1. Primary

    Time frame: 12 months

    Outcome measure 1: Number and proportion of MyRenalCare users by age, sex, ethnicity and Index of Multiple Deprivation quintile, compared with the CKD population under Wessex Kidney Centre care. Prevalence ratios will also be calculated.

  2. Primary

    Time frame: 12-months

    Outcome measure 2:

    Composite digital adherence score (0-100) for MyRenalCare users, combining log-in frequency, completeness of blood pressure and symptom entries, use of secure messaging and duration of sustained use. Analyses stratified by age, sex, ethnicity and deprivation.

Secondary outcomes

  1. Secondary

    Time frame: 12-months

    Outcome measure1: Number of unplanned and planned hospital admissions for MyRenalCare users compared with matched usual-care controls.

  2. Secondary

    Time frame: 12-months

    Outcome measure 2: Number of outpatient visits (renal and non-renal) for MyRenalCare users compared with matched usual-care controls.

  3. Secondary

    Time frame: 12-months

    Outcome measure 3: CKD progression, measured by change in eGFR, movement between CKD stages, and initiation of kidney replacement therapy for MyRenalCare users versus matched controls.

  4. Secondary

    Time frame: 12-months

    Outcome measure 4: NHS healthcare costs per patient-year for MyRenalCare users compared with matched usual-care controls, including inpatient, outpatient, emergency and relevant community or virtual care contacts.

  5. Secondary

    Time frame: 12-months

    Outcome measure 5: Estimated patient travel-related CO₂ emissions for renal care appointments for MyRenalCare users versus matched usual-care controls, based on travel distance and mode.

  6. Secondary

    Time frame: 12-months

    Outcome measure 6: Themes from qualitative interviews with patients and staff on MyRenalCare usability, support needs, barriers and facilitators to digital engagement.

Study contacts

Contact information is provided by the study sponsor or research team.

Sam Newman

CONTACT

[email protected]

+442392286000 ext. 5153

Sponsors and collaborators

Lead sponsor

Portsmouth Hospitals NHS Trust

Other Gov

Collaborators

  • Ardia Digital Health Ltd

Registry information

Acronym: INCLUDE-CKD

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 29, 2026
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.